Kyntra Bio (KYNB) director receives 7,000 options at $7.13 strike
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Kyntra Bio director Jeffrey L. Edwards received a grant of stock options covering 7,000 shares of common stock. The options have an exercise price of $7.13 per share and were granted as a compensation award rather than a market purchase or sale.
The award vests in four equal quarterly installments measured from the grant date and expires on June 11, 2036. Following this grant, Edwards holds options for 7,000 shares directly, giving him equity-based incentive aligned with the company’s future performance.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
EDWARDS JEFFREY L
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 7,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 7,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 7,000 shares
Exercise price: $7.13 per share
Total options after grant: 7,000 shares
+3 more
6 metrics
Options granted
7,000 shares
Stock Option (Right to Buy) awarded to director
Exercise price
$7.13 per share
Conversion or exercise price of the stock options
Total options after grant
7,000 shares
Total derivative shares following the transaction
Grant date
June 12, 2026
Transaction date for the option award
Expiration date
June 11, 2036
Option term end date if not exercised
Vesting schedule
Four equal quarterly installments
Measured from date of grant per footnote
Key Terms
Stock Option (Right to Buy), exercise price, vest in four equal quarterly installments, expiration date
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 7.1300"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in four equal quarterly installments financial
"The shares subject to the option shall vest in four equal quarterly installments"
expiration date financial
"expiration_date: 2036-06-11T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What did KYNTRA BIO (KYNB) director Jeffrey L. Edwards report on this Form 4?
Jeffrey L. Edwards reported receiving a grant of stock options for 7,000 shares of Kyntra Bio common stock. These were awarded as director compensation, not bought on the open market, and provide potential future ownership if exercised.
What is the exercise price of the KYNTRA BIO (KYNB) options granted to Jeffrey L. Edwards?
The stock options granted to Jeffrey L. Edwards have an exercise price of $7.13 per share. This means he can buy Kyntra Bio common stock at $7.13 if he exercises the options after they vest and before expiration.
When do Jeffrey L. Edwards’ KYNTRA BIO (KYNB) stock options vest?
The options granted to Jeffrey L. Edwards vest in four equal quarterly installments measured from the grant date. This staggered vesting schedule rewards continued board service over time rather than immediately providing fully vested options.
When do the KYNTRA BIO (KYNB) stock options granted to Jeffrey L. Edwards expire?
The stock options granted to Jeffrey L. Edwards expire on June 11, 2036. He must exercise any vested options before that expiration date; otherwise, the right to purchase the underlying Kyntra Bio shares lapses.